David Lamond - 20 May 2022 Form 4 Insider Report for Applied Molecular Transport Inc.

Role
Director
Signature
/s/ Brandon Hants Attorney-in-Fact for David Lamond
Issuer symbol
N/A
Transactions as of
20 May 2022
Net transactions value
+$210,850
Form type
4
Filing time
23 May 2022, 18:18:19 UTC
Previous filing
23 May 2022
Next filing
26 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMTI Common Stock Purchase $101,640 +33,000 +3.3% $3.08* 1,044,019 20 May 2022 By Trust F1, F2
transaction AMTI Common Stock Purchase $109,210 +33,500 +3.2% $3.26* 1,077,519 23 May 2022 By Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.03 to $3.14, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 These shares are held directly by the Blue Devil Trust for which the Reporting Person serves as trustee.
F3 The price reported in column is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.32, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.